Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
M	O
Service:	O
MEDICINE	O
Allergies:	O
Morphine	O
/	O
Coricidin	O
HBP	O
Attending:	O
___.	O
Chief	O
Complaint:	O
confusion,	B-Delirium
altered	B-Delirium
mental	B-Delirium
status	B-Delirium
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
Chest	O
tube	O
placements	O
History	O
of	O
Present	O
Illness:	O
___	O
y/o	O
M	O
with	O
PMhx	O
of	O
CAD	O
s/p	O
CABG	O
in	O
___,	O
NSTEMI,	O
systolic	O
CHF	O
(EF	O
35-40%),	O
PVD	O
s/p	O
bypass,	O
CKD	O
stage	O
III,	O
history	O
of	O
LLE	O
DVT	O
s/p	O
IVC	O
filter,	O
chronic	O
SDH,	B-Intracranial_haemorrhage
Dementia	B-Dementia
and	O
frequent	O
falls	B-Falls
who	O
was	O
sent	O
in	O
from	O
his	O
SNF	B-Lives_in_carehome
due	O
to	O
worsening	O
confusion	O
over	O
the	O
last	O
few	O
days	O
since	O
recent	O
fall.	B-Falls
Pt	O
was	O
initially	O
seen	O
at	O
___	O
and	O
referred	O
to	O
___	O
due	O
to	O
concern	O
for	O
acute	O
on	O
chronic	O
component	O
to	O
his	O
SDH.	B-Intracranial_haemorrhage
Pt	O
was	O
seen	O
by	O
NSG	O
in	O
the	O
ED	O
and	O
serial	O
head	O
CTs	O
have	O
been	O
unchanged,	O
not	O
felt	O
to	O
require	O
any	O
intervention	O
or	O
ICU	O
level	O
monitoring.	O
ED	O
eval	O
was	O
notable	O
for	O
positive	O
UA	O
and	O
concern	O
for	O
possible	O
LLE	O
cellulitis.	O
Pt	O
was	O
treated	O
with	O
Clindamycin	O
and	O
Cefriaxone	O
prior	O
to	O
admission	O
to	O
the	O
floor.	O
On	O
arrival	O
to	O
the	O
floor,	O
pt	O
was	O
denying	O
any	O
complaints	O
and	O
was	O
asking	O
for	O
breakfast.	O
He	O
denies	O
any	O
CP,	O
SOB,	O
HA,	O
fevers,	O
cough,	O
abd	O
pain,	O
dysuria	O
___	O
edema.	O
No	O
___	O
pain	O
and	O
reports	O
walking	O
with	O
walker	B-Mobile_with_aid
at	O
baseline.	O
He	O
does	O
report	O
some	O
constipation	B-Constipation
and	O
was	O
noted	O
to	O
have	O
a	O
stage	O
II	O
sacral	O
decub	O
today.	O
Additional	O
history	O
was	O
obtained	O
from	O
his	O
___	O
who	O
reports	O
that	O
he	O
has	O
frequent	O
falls	B-Falls
and	O
is	O
often	O
in	O
a	O
wheelchair	B-Mobile_with_aid
at	O
the	O
SNF	B-Lives_in_carehome
because	O
of	O
his	O
fall	B-Falls
risk.	O
She	O
feels	O
that	O
he	O
may	O
not	O
be	O
a	O
reliable	O
historian	O
and	O
often	O
minimizes	O
symptoms.	O
12	O
pt	O
ROS	O
otherwise	O
negative	O
Past	O
Medical	O
History:	O
-	O
Systolic	O
CHF	O
(EF	O
35-40%,	O
___	O
-	O
Dementia	B-Dementia
-	O
UGIB	B-Upper_gastrointestinal_haemorrhage
___	O
s/p	O
endoscopic	O
control	O
of	O
duodenal	B-Upper_gastrointestinal_haemorrhage
ulcer	O
hemorrhage	B-Upper_gastrointestinal_haemorrhage
-	O
PVD	O
s/p	O
right	O
limb	O
ischemia	O
s/p	O
Right	O
Femoral-Peroneal	O
Bypass	O
with	O
Left	O
Reversed	O
Saphenous	O
Vein	O
Graft	O
___	O
-	O
NSTEMI	O
(Type	O
II;	O
___	O
-	O
CABG	O
x	O
2	O
in	O
___,	O
___-LAD,	O
s/p	O
angioplasty	O
x	O
5	O
-	O
Hypertension	O
-	O
Hyperlipidemia	O
-	O
Diabetes	O
mellitus,	O
type	O
II	O
-	O
Left-sided	O
Sensory	O
Seizures	B-Seizures
-	O
well	O
controlled	O
on	O
Dilantin	O
described	O
by	O
the	O
patient	O
as	O
a	O
tingling	O
in	O
his	O
left	O
cheek	O
and	O
left	O
arm	O
from	O
shoulder	O
to	O
elbow,	O
sometimes	O
spreading	O
down	O
his	O
torso	O
and	O
left	O
leg.	O
He	O
has	O
never	O
had	O
a	O
generalized	O
seizure	B-Seizures
(other	O
than	O
possibly	O
one	O
in	O
the	O
setting	O
of	O
taking	O
morphine	O
where	O
he	O
had	O
bilateral	O
arm	O
haking)	O
-	O
CKD,	O
stage	O
III	O
-	O
Arthritis	O
-	O
Chronic	O
subdural	B-Intracranial_haemorrhage
hematoma	B-Intracranial_haemorrhage
-	O
History	O
of	O
LLE	O
DVT,	O
___	O
Social	O
History:	O
___	O
Family	O
History:	O
(per	O
OMR)	O
-	O
negative	O
for	O
stroke,	O
seizure,	B-Seizures
movement	O
disorders,	O
known	O
neurological	O
conditions	O
other	O
than	O
migarine	O
-	O
positive	O
for	O
CAD/MIs	O
(mother,	O
father),	O
migraine	O
(mother)	O
Physical	O
Exam:	O
Admission	O
exam	O
VITALS:	O
97.9	O
HR	O
95	O
BP	O
119/65	O
RR	O
18	O
Sats	O
97%	O
RA	O
GENERAL:	O
Alert	O
elderly	O
male	O
in	O
no	O
apparent	O
distress	O
EYES:	O
Anicteric,	O
pupils	O
equally	O
round	O
ENT:	O
MMM	O
CV:	O
RRR	O
RESP:	O
Crackles	O
at	O
LLL	O
>	O
RLL,	O
no	O
wheezes	O
GI:	O
Abdomen	O
soft,	O
non-distended,	O
non-tender	O
to	O
palpation.	O
Bowel	O
sounds	O
present.	O
GU:	O
No	O
suprapubic	O
fullness	O
or	O
tenderness	O
to	O
palpation	O
SKIN:	O
BLE	O
erythema	O
and	O
edema,	O
L>R,	O
mild	O
warmth	O
without	O
TTP	O
NEURO:	O
oriented	O
to	O
city,	O
reports	O
year	O
as	O
___,	O
month	O
of	O
___	O
EOMI,	O
speech	O
fluent,	O
no	O
facial	O
asymmetry,	O
HOH	O
but	O
moves	O
all	O
limbs,	O
sensation	O
to	O
light	O
touch	O
grossly	O
intact	O
throughout	O
Discharge	O
exam	O
GENERAL:	O
Alert	O
and	O
in	O
no	O
apparent	O
distress,	O
resting	O
in	O
bed	O
EYES:	O
Anicteric,	O
pupils	O
equally	O
round	O
ENT:	O
Ears	O
and	O
nose	O
without	O
visible	O
erythema,	O
masses,	O
or	O
trauma.	O
Oropharynx	O
without	O
visible	O
lesion,	O
erythema	O
or	O
exudate	O
CV:	O
Heart	O
regular,	O
no	O
murmur,	O
no	O
S3,	O
no	O
S4.	O
No	O
JVD.	O
RESP:	O
Breathing	O
is	O
non-labored,	O
mildly	O
diminished	O
at	O
bases,	O
occasional	O
___	O
rhonchi,	O
no	O
wheezing,	O
L	O
chest	O
tube	O
has	O
now	O
been	O
removed,	O
dressing	O
c/d/I,	O
serosang	O
drainage	O
GI:	O
Abdomen	O
soft,	O
non-distended,	O
non-tender	O
to	O
palpation.	O
Bowel	O
sounds	O
present.	O
No	O
HSM	O
GU:	O
No	O
suprapubic	O
fullness	O
or	O
tenderness	O
to	O
palpation	O
MSK:	O
Neck	O
supple,	O
moves	O
all	O
extremities,	O
strength	O
grossly	O
full	O
and	O
symmetric	O
bilaterally	O
in	O
all	O
limbs,	O
L	O
leg	O
swollen	O
>	O
R	O
leg,	O
chronic	O
SKIN:	O
venous	O
stasis	O
dermatitis	O
over	O
___	O
NEURO:	O
alert,	O
oriented	O
to	O
self	O
(name,	O
DOB),	O
not	O
oriented	O
to	O
place	O
or	O
time.	O
PSYCH:	O
at	O
times	O
uncooperative	O
Pertinent	O
Results:	O
Admission	O
labs	O
___	O
10:25AM	O
BLOOD	O
WBC-11.3*#	O
RBC-3.58*	O
Hgb-10.8*	O
Hct-32.9*	O
MCV-92	O
MCH-30.2	O
MCHC-32.8	O
RDW-14.3	O
RDWSD-48.4*	O
Plt	O
___	O
___	O
10:25AM	O
BLOOD	O
Glucose-224*	O
UreaN-44*	O
Creat-1.2	O
Na-138	O
K-4.0	O
Cl-93*	O
HCO3-30	O
AnGap-15	O
URINE	O
CULTURE	O
(Final	O
___:	O
ESCHERICHIA	O
COLI.	O
>100,000	O
CFU/mL.	O
Cefazolin	O
interpretative	O
criteria	O
are	O
based	O
on	O
a	O
dosage	O
regimen	O
of	O
2g	O
every	O
8h.	O
SENSITIVITIES:	O
MIC	O
expressed	O
in	O
MCG/ML	O
_________________________________________________________	O
ESCHERICHIA	O
COLI	O
|	O
AMPICILLIN------------	O
=>32	O
R	O
AMPICILLIN/SULBACTAM--	O
16	O
I	O
CEFAZOLIN-------------	O
<=4	O
S	O
CEFEPIME--------------	O
<=1	O
S	O
CEFTAZIDIME-----------	O
<=1	O
S	O
CEFTRIAXONE-----------	O
<=1	O
S	O
CIPROFLOXACIN---------	O
0.5	O
S	O
GENTAMICIN------------	O
=>16	O
R	O
MEROPENEM-------------<=0.25	O
S	O
NITROFURANTOIN--------	O
<=16	O
S	O
PIPERACILLIN/TAZO-----	O
<=4	O
S	O
TOBRAMYCIN------------	O
2	O
S	O
TRIMETHOPRIM/SULFA----	O
=>___hest	O
___	O
IMPRESSION:	O
1.	O
5.1	O
x	O
7.3	O
cm	O
area	O
of	O
dense	O
airspace	O
opacification	O
with	O
rounded	O
margins	O
in	O
the	O
left	O
lower	O
lobe	O
with	O
adjacent	O
patchy	O
peribronchial	O
opacities	O
and	O
small	O
pleural	O
effusion	O
is	O
new	O
compared	O
to	O
the	O
prior	O
chest	O
radiograph	O
of	O
___,	O
but	O
grossly	O
unchanged	O
since	O
the	O
more	O
recent	O
radiographs	O
dating	O
back	O
to	O
___.	O
The	O
most	O
worrisome	O
differential	O
consideration	O
is	O
malignancy.	O
Alternatively,	O
this	O
could	O
be	O
due	O
to	O
infection.	O
Rounded	O
atelectasis	O
is	O
possible	O
but	O
less	O
likely.	O
2.	O
A	O
0.5	O
x	O
1.2	O
cm	O
rounded	O
density	O
along	O
the	O
dependent	O
portion	O
of	O
the	O
right	O
mainstem	O
bronchus	O
probably	O
represents	O
secretions,	O
although	O
an	O
endobronchial	O
lesion	O
cannot	O
be	O
entirely	O
excluded.	O
3.	O
2	O
mm	O
nodule	O
in	O
the	O
right	O
lung	O
apex.	O
RECOMMENDATION(S):	O
Recommend	O
empiric	O
therapy	O
with	O
short	O
term	O
repeat	O
CT	O
examination	O
with	O
contrast	O
after	O
completion	O
of	O
therapy.	O
If	O
this	O
finding	O
persists	O
or	O
worsens	O
at	O
that	O
time,	O
PET-CT	O
or	O
direct	O
tissue	O
sampling	O
should	O
be	O
considered.	O
The	O
area	O
of	O
dependent	O
density	O
in	O
the	O
right	O
mainstem	O
bronchus	O
can	O
be	O
followed	O
up	O
at	O
that	O
time	O
as	O
well.	O
CT	O
C/A/P	O
___	O
IMPRESSION:	O
1.	O
Left	O
lower	O
lobe	O
collapse,	O
new	O
since	O
the	O
prior	O
study.	O
An	O
underlying	O
infectious	O
process	O
cannot	O
be	O
excluded.	O
2.	O
New	O
loculated	O
left	O
pleural	O
effusions	O
abutting	O
the	O
left	O
upper	O
and	O
left	O
lower	O
lobes.	O
Radiology	O
ReportCT	O
CHEST	O
W/O	O
CONTRASTStudy	O
Date	O
of	O
___	O
6:08	O
___	O
___	O
6:___HEST	O
W/O	O
CONTRAST	O
Clip	O
#	O
___	O
Reason:	O
___	O
year	O
old	O
man	O
with	O
L-sided	O
loculated	O
pleural	O
effusions	O
s/p	O
pigtail	O
placement	O
___	O
___.	O
?residual	O
effusion	O
UNDERLYING	O
MEDICAL	O
CONDITION:	O
Loculated	O
pleural	O
effusiion	O
REASON	O
FOR	O
THIS	O
EXAMINATION:	O
___	O
year	O
old	O
man	O
with	O
L-sided	O
loculated	O
pleural	O
effusions	O
s/p	O
pigtail	O
placement	O
___	O
___.	O
?residual	O
effusion	O
CONTRAINDICATIONS	O
FOR	O
IV	O
CONTRAST:	O
CKD	O
Final	O
Report	O
EXAMINATION:	O
CT	O
CHEST	O
W/O	O
CONTRAST	O
INDICATION:	O
Loculated	O
pleural	O
effusiion//	O
___	O
year	O
old	O
man	O
with	O
L-sided	O
loculated	O
pleural	O
effusions	O
s/p	O
pigtail	O
placement	O
___	O
___.	O
?residual	O
effusion	O
TECHNIQUE:	O
Serial	O
axial	O
sections	O
were	O
performed	O
through	O
the	O
chest.	O
Reconstructed	O
coronal	O
and	O
sagittal	O
images	O
were	O
generated.	O
Axial	O
maximal	O
intensity	O
projection	O
reformatted	O
images	O
were	O
performed.	O
DOSE:	O
Acquisition	O
sequence:	O
1)	O
Spiral	O
Acquisition	O
6.5	O
s,	O
34.2	O
cm;	O
CTDIvol	O
=	O
8.3	O
mGy	O
(Body)	O
DLP	O
=	O
286.7	O
mGy-cm.	O
Total	O
DLP	O
(Body)	O
=	O
287	O
mGy-cm.	O
COMPARISON:	O
CT	O
scan	O
of	O
the	O
chest	O
from	O
___.	O
FINDINGS:	O
NECK,	O
THORACIC	O
INLET,	O
AXILLAE,	O
CHEST	O
WALL:	O
The	O
thyroid	O
gland	O
is	O
unremarkable.	O
There	O
is	O
no	O
supraclavicular	O
or	O
axillary	O
adenopathy.	O
UPPER	O
ABDOMEN:	O
The	O
study	O
is	O
not	O
tailored	O
for	O
evaluation	O
of	O
the	O
upper	O
abdomen	O
however	O
the	O
upper	O
abdomen	O
appears	O
stable	O
when	O
compared	O
to	O
the	O
recent	O
study.	O
MEDIASTINUM:	O
There	O
is	O
a	O
stable	O
sub	O
aortic	O
1	O
cm	O
lymph	O
node.	O
There	O
are	O
several	O
additional	O
smaller	O
mediastinal	O
lymph	O
nodes	O
which	O
are	O
within	O
the	O
range	O
of	O
normal	O
in	O
size	O
for	O
cross-sectional	O
imaging.	O
HEART	O
and	O
PERICARDIUM:	O
The	O
patient	O
is	O
status	O
post	O
sternotomy	O
and	O
CABG.	O
Coronary	O
artery	O
and	O
cardiac	O
valve	O
calcification	O
is	O
re-demonstrated.	O
PLEURA:	O
There	O
is	O
a	O
loculated	O
left	O
pleural	O
effusion.	O
There	O
is	O
a	O
left-sided	O
pigtail	O
catheter.	O
Previously	O
seen	O
large	O
fluid	O
pocket	O
has	O
resolved.	O
There	O
is	O
persistence	O
of	O
a	O
smaller	O
loculated	O
air	O
and	O
fluid	O
collection	O
which	O
appears	O
similar.	O
LUNG:	O
1.	O
PARENCHYMA:	O
There	O
is	O
centrilobular	O
emphysema,	O
most	O
prominent	O
in	O
the	O
upper	O
lobes.	O
Atelectatic	O
changes	O
are	O
noted	O
in	O
the	O
lingula	O
and	O
left	O
lower	O
lobe	O
this	O
is	O
not	O
significantly	O
changed.	O
2.	O
AIRWAYS:	O
There	O
is	O
likely	O
mild	O
bronchial	O
wall	O
thickening	O
in	O
the	O
right	O
lower	O
lobe.	O
3.	O
VESSELS:	O
The	O
aorta	O
is	O
atherosclerotic	O
and	O
tortuous.	O
CHEST	O
CAGE:	O
Degenerative	O
changes	O
are	O
evident.	O
IMPRESSION:	O
There	O
is	O
a	O
left	O
pigtail	O
catheter	O
with	O
resolution	O
of	O
a	O
previously	O
noted	O
large	O
loculated	O
fluid	O
pocket.	O
Persistence	O
of	O
smaller	O
loculated	O
air-fluid	O
collection	O
and	O
small	O
left	O
effusion	O
with	O
associated	O
atelectasis.	O
Emphysematous	O
changes.	O
Vascular	O
and	O
heart	O
valve	O
calcification.	O
Stable	O
sub	O
aortic	O
1	O
cm	O
lymph	O
node.	O
___,	O
MD	O
electronically	O
signed	O
on	O
SAT	O
___	O
8:53	O
___	O
___	O
03:50PM	O
PLEURAL	O
___	O
Polys-75*	O
Lymphs-3*	O
Monos-22*	O
___	O
03:37PM	O
PLEURAL	O
___	O
Polys-92*	O
Lymphs-3*	O
Monos-3*	O
Eos-2*	O
___	O
03:50PM	O
PLEURAL	O
TotProt-4.2	O
Glucose-94	O
LD(LDH)-4010	O
Amylase-22	O
___	O
Misc-BODY	O
FLUID	O
___	O
03:37PM	O
PLEURAL	O
TotProt-4.6	O
Glucose-194	O
LD(LDH)-831	O
Albumin-2.2	O
Cholest-99	O
___	O
03:37PM	O
OTHER	O
BODY	O
FLUID	O
Misc-BODY	O
FLUID	O
___	O
3:37	O
pm	O
PLEURAL	O
FLUID	O
GRAM	O
STAIN	O
(Final	O
___:	O
2+	O
___	O
per	O
1000X	O
FIELD):	O
POLYMORPHONUCLEAR	O
LEUKOCYTES.	O
NO	O
MICROORGANISMS	O
SEEN.	O
FLUID	O
CULTURE	O
(Final	O
___:	O
NO	O
GROWTH.	O
ANAEROBIC	O
CULTURE	O
(Final	O
___:	O
NO	O
GROWTH.	O
FUNGAL	O
CULTURE	O
(Preliminary):	O
NO	O
FUNGUS	O
ISOLATED.	O
ACID	O
FAST	O
SMEAR	O
(Final	O
___:	O
NO	O
ACID	O
FAST	O
BACILLI	O
SEEN	O
ON	O
DIRECT	O
SMEAR.	O
ACID	O
FAST	O
CULTURE	O
(Preliminary):	O
NO	O
MYCOBACTERIA	O
ISOLATED.	O
Brief	O
Hospital	O
Course:	O
___	O
y/o	O
M	O
with	O
PMhx	O
of	O
CAD	O
s/p	O
CABG	O
in	O
___,	O
NSTEMI,	O
systolic	O
CHF(EF	O
35-40%),	O
PVD	O
s/p	O
bypass,	O
CKD	O
stage	O
III,	O
history	O
of	O
LLE	O
DVT	O
s/p	O
IVC	O
filter,	O
chronic	O
SDH	B-Intracranial_haemorrhage
and	O
Dementia	B-Dementia
who	O
p/w	O
acute	O
encephalopathy	O
#	O
Acute	O
on	O
chronic	O
SDH:	B-Intracranial_haemorrhage
patient	O
was	O
evaluated	O
by	O
neurosurgery,	O
___	O
noted	O
to	O
be	O
stable	O
on	O
serial	O
CTs.	O
NSGY	O
recommended	O
holding	O
ASA	O
for	O
1	O
week	O
and	O
avoiding	O
anticoagulation.	O
ASA	O
was	O
restarted	O
on	O
___.	O
He	O
will	O
follow	O
up	O
after	O
discharge	O
with	O
Dr.	O
___	O
neurology.	O
Patient	O
has	O
an	O
outpatient	O
CT	O
scheduled	O
at	O
the	O
end	O
of	O
___	O
for	O
serial	O
follow-up.	O
#	O
Fevers	O
#	O
Sepsis	O
#	O
Encephalopathy	O
#	O
Pneumonia	B-Lower_respiratory_tract_infection
with	O
parapneumonic	B-Lower_respiratory_tract_infection
effusion:	O
Initially,	O
patient	O
thought	O
to	O
be	O
altered	O
secondary	O
to	O
UTI	B-Urinary_tract_infection
vs.	O
PNA	B-Lower_respiratory_tract_infection
as	O
CXR	O
and	O
CT	O
demonstrated	O
LLL	O
consolidation.	O
He	O
was	O
initially	O
on	O
ceftriaxone.	O
UCx	O
grew	O
pan-susceptible	O
E.	O
COli	O
and	O
patient	O
was	O
transitioned	O
to	O
cepfodoxime	O
and	O
azithro	O
for	O
both	O
UTI	B-Urinary_tract_infection
and	O
PNA.	B-Lower_respiratory_tract_infection
However	O
on	O
evening	O
of	O
___,	O
patient	O
developed	O
sepsis	O
with	O
fever,	O
hypotension	O
and	O
worsening	O
leukocytosis.	O
He	O
was	O
broadened	O
to	O
vanc	O
and	O
cefepime.	O
WBC	O
the	O
following	O
morning	O
noted	O
to	O
be	O
25.	O
CT	O
C/A/P	O
was	O
ordered	O
to	O
evaluate	O
for	O
etiology	O
of	O
sepsis.	O
CT	O
demonstrated	O
LLL	O
collpasse	O
and	O
loculated	O
effusion.	O
Interventional	O
pulm	O
was	O
consulted	O
and	O
placed	O
a	O
chest	O
tube	O
at	O
the	O
bedside.	O
Pleural	O
studies	O
consistent	O
with	O
exudative	O
effusion	O
-	O
cultures	O
and	O
cytology	O
were	O
however	O
negative.	O
WBC	O
continued	O
to	O
rise	O
to	O
___	O
and	O
flagyl	O
was	O
added.	O
ID	O
was	O
consulted	O
and	O
recommended	O
ceftriaxone	O
and	O
flagyl	O
given	O
some	O
concern	O
for	O
aspiration.	O
His	O
white	O
count	O
then	O
began	O
to	O
improve.	O
Repeat	O
CT	O
scan	O
showed	O
another	O
area	O
in	O
the	O
L	O
lung	O
with	O
loculated	O
effusion	O
therefore	O
a	O
second	O
chest	O
tube	O
was	O
placed	O
on	O
___	O
by	O
___	O
per	O
family's	O
request.	O
ID	O
recommended	O
ceftriaxone	O
and	O
flagyl	O
until	O
___	O
(further	O
course	O
to	O
be	O
determined	O
at	O
that	O
time)	O
and	O
midline	O
was	O
placed	O
however	O
patient	O
delirious	O
overnight	O
on	O
___	O
and	O
pulled	O
midline.	O
He	O
was	O
therefore	O
continued	O
on	O
IM	O
ceftriaxone	O
and	O
PO	O
flagyl	O
to	O
complete	O
his	O
course	O
trhough	O
___	O
#	O
Dementia	B-Dementia
#	O
Delerium	B-Delirium
-	O
patient	O
with	O
baseline	O
dementia	B-Dementia
and	O
fluctuations	O
in	O
behavior	O
however	O
worsened	O
over	O
past	O
few	O
days	O
likely	O
from	O
prolonged	O
admission	O
as	O
well	O
as	O
infection.	O
He	O
required	O
prn	O
zyprexa	O
and	O
Haldol	O
in	O
order	O
for	O
nursing	O
to	O
provide	O
care.	O
Psych	O
was	O
consulted	O
on	O
___	O
and	O
recommended	O
standing	O
Haldol	O
as	O
well	O
as	O
ramelteon	O
to	O
improve	O
sleep	O
wake	O
cycle.	O
#	O
CT	O
chest	O
with	O
LLL	O
PNA	B-Lower_respiratory_tract_infection
vs.	O
mass	O
-	O
CT	O
chest	O
findings	O
as	O
above,	O
discussed	O
with	O
daughter,	O
she	O
preferred	O
patient	O
not	O
to	O
be	O
informed	O
of	O
potential	O
for	O
cancer	O
and	O
only	O
be	O
told	O
findings	O
are	O
due	O
to	O
a	O
PNA.	B-Lower_respiratory_tract_infection
Cytology	O
on	O
initial	O
thoracentesis	O
was	O
negative,	O
___	O
___	O
was	O
pending	O
at	O
time	O
of	O
discharge.	O
#	O
Acute	O
kidney	O
injury	O
on	O
CKD	O
-	O
patient	O
with	O
baseline	O
CKD	O
and	O
Cr	O
1.2.	O
He	O
developed	O
___	O
on	O
___	O
likely	O
in	O
setting	O
of	O
sepsis	O
as	O
well	O
as	O
receiving	O
IV	O
contrast.	O
His	O
Cr	O
peaked	O
at	O
2.9.	O
Diuretics	O
were	O
held.	O
Urine	O
studies	O
were	O
consistent	O
with	O
pre-renal	O
etiology.	O
Renal	O
was	O
consulted	O
and	O
recommended	O
IVF	O
for	O
goal	O
___	O
input	O
per	O
day.	O
His	O
Cr	O
improved	O
and	O
returned	O
to	O
baseline.	O
#	O
Urinary	O
retention	O
-	O
patient	O
requiring	O
frequent	O
straight	O
caths	O
for	O
large	O
PVRs,	O
likely	O
in	O
setting	O
of	O
large	O
stool	O
burden	O
and	O
constipation	B-Constipation
with	O
overflow	O
incontinence.	O
He	O
was	O
started	O
on	O
Flomax	O
and	O
finasteride.	O
Foley	O
catheter	O
was	O
placed	O
___.	O
Patient	O
failed	O
voiding	O
trial	O
on	O
___	O
Foley	O
subsequently	O
placed	O
and	O
started	O
on	O
tamsulosin	O
with	O
intent	O
for	O
voiding	O
trial	O
with	O
urology.	O
#	O
chronic	O
systolic	O
CHF:	O
Initially	O
Pt	O
clinically	O
volume	O
overloaded,	O
however	O
now	O
then	O
appeared	O
dry	O
and	O
developed	O
___.	O
Diuretics	O
and	O
BB	O
were	O
held	O
in	O
setting	O
of	O
sepsis.	O
Diuretics	O
(torsemide)	O
and	O
KCl	O
supplement	O
still	O
on	O
hold	O
at	O
discharge.	O
#	O
CAD	O
s/p	O
CABG:	O
cont	O
statin,	O
BB,	O
ASA	O
restarted	O
___,	O
Imdur	O
restarted	O
___	O
TRANSITIONAL	O
ISSUES	O
-	O
Diuretics	O
were	O
held	O
at	O
discharge.	O
Please	O
follow-up	O
patient's	O
volume	O
and	O
respiratory	O
status	O
and	O
re-institute	O
when	O
able.	O
-	O
Please	O
check	O
chem	O
10	O
within	O
one	O
week	O
of	O
discharge	O
for	O
renal	O
function	O
-	O
Patient	O
failed	O
inpatient	O
voiding	O
trial;	O
started	O
on	O
tamsulosin	O
and	O
will	O
need	O
voiding	O
trial	O
at	O
___,	O
and	O
if	O
fails,	O
with	O
___	O
clinic.	O
-	O
Patient	O
will	O
need	O
repeat	O
chest	O
imaging	O
in	O
___	O
weeks	O
to	O
see	O
if	O
chest	O
mass	O
improved	O
with	O
antibiotics	O
(concern	O
for	O
underlying	O
malignancy).	O
-	O
In	O
discussion	O
with	O
patient's	O
daughter	O
(HCP)	O
she	O
did	O
not	O
feel	O
patient	O
nor	O
family	O
would	O
want	O
treatment	O
should	O
mass	O
turn	O
out	O
to	O
be	O
malignancy,	O
and	O
that	O
this	O
potential	O
information	O
should	O
be	O
withheld	O
form	O
him.	O
-	O
Patient	O
will	O
require	O
follow-up	O
NCHCT	O
for	O
___	O
on	O
___.	O
-	O
Scheduled	O
follow-up	O
with	O
neurosurgery	O
-	O
Antibiotic	O
course	O
with	O
ceftriaxone	O
and	O
flagyl	O
until	O
___	O
(further	O
course	O
to	O
be	O
determined	O
at	O
that	O
time	O
by	O
ID	O
appointment)	O
-	O
Patient	O
significantly	O
deconditioned,	O
will	O
need	O
___	O
-	O
Patient	O
started	O
on	O
standing	O
Haldol	O
by	O
psychiatry	O
for	O
agitation;	O
please	O
monitor	O
QTc	O
and	O
symptoms;	O
adjust	O
medicaitons	O
as	O
needed.	O
>	O
30	O
minutes	O
spent	O
coordinating	O
discharge	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
2.	O
Atorvastatin	O
80	O
mg	O
PO	O
QPM	O
3.	O
Isosorbide	O
Mononitrate	O
(Extended	O
Release)	O
30	O
mg	O
PO	O
DAILY	O
4.	O
Metoprolol	O
Succinate	O
XL	O
25	O
mg	O
PO	O
DAILY	O
5.	O
Metolazone	O
2.5	O
mg	O
PO	O
3X/WEEK	O
(___)	O
6.	O
Phenytoin	O
(Suspension)	O
300	O
mg	O
PO	O
3X/WEEK	O
(___)	O
7.	O
Phenytoin	O
(Suspension)	O
400	O
mg	O
PO	O
4X/WEEK	O
(___)	O
8.	O
Potassium	O
Chloride	O
20	O
mEq	O
PO	O
DAILY	O
9.	O
Pantoprazole	O
40	O
mg	O
PO	O
Q24H	O
10.	O
Torsemide	O
40	O
mg	O
PO	O
DAILY	O
11.	O
Acetaminophen	O
650	O
mg	O
PO	O
Q6H:PRN	O
Pain	O
-	O
Mild	O
12.	O
Bisacodyl	O
10	O
mg	O
PR	O
QHS:PRN	O
constipation	B-Constipation
13.	O
Milk	O
of	O
Magnesia	O
30	O
mL	O
PO	O
Q6H:PRN	O
constipation	B-Constipation
14.	O
GuaiFENesin	O
___	O
mL	O
PO	O
Q6H:PRN	O
cough	O
15.	O
Nitroglycerin	O
SL	O
0.3	O
mg	O
SL	O
Q5MIN:PRN	O
chest	O
pain	O
Discharge	O
Medications:	O
1.	O
CefTRIAXone	O
2	O
g	O
IM	O
Q24H	O
To	O
continue	O
through	O
___,	O
then	O
transition	O
to	O
PO	O
cefpodoxime	O
100	O
mg	O
PO	O
BID	O
on	O
___.	O
2.	O
Docusate	O
Sodium	O
100	O
mg	O
PO	O
BID	O
3.	O
Finasteride	O
5	O
mg	O
PO	O
DAILY	O
4.	O
Haloperidol	O
2.5	O
mg	O
PO	O
BID	O
5.	O
Lactulose	O
30	O
mL	O
PO	O
BID	O
6.	O
MetroNIDAZOLE	O
500	O
mg	O
PO/NG	O
Q8H	O
6-week	O
course	O
due	O
to	O
end	O
on	O
___.	O
7.	O
Senna	O
17.2	O
mg	O
PO	O
BID	O
8.	O
Tamsulosin	O
0.8	O
mg	O
PO	O
QHS	O
9.	O
Vitamin	O
D	O
___	O
UNIT	O
PO	O
1X/WEEK	O
(WE)	O
10.	O
Acetaminophen	O
650	O
mg	O
PO	O
Q6H:PRN	O
Pain	O
-	O
Mild	O
11.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
12.	O
Atorvastatin	O
80	O
mg	O
PO	O
QPM	O
13.	O
Bisacodyl	O
10	O
mg	O
PR	O
QHS:PRN	O
constipation	B-Constipation
14.	O
GuaiFENesin	O
___	O
mL	O
PO	O
Q6H:PRN	O
cough	O
15.	O
Isosorbide	O
Mononitrate	O
(Extended	O
Release)	O
30	O
mg	O
PO	O
DAILY	O
16.	O
Metoprolol	O
Succinate	O
XL	O
25	O
mg	O
PO	O
DAILY	O
17.	O
Milk	O
of	O
Magnesia	O
30	O
mL	O
PO	O
Q6H:PRN	O
constipation	B-Constipation
18.	O
Nitroglycerin	O
SL	O
0.3	O
mg	O
SL	O
Q5MIN:PRN	O
chest	O
pain	O
19.	O
Pantoprazole	O
40	O
mg	O
PO	O
Q24H	O
20.	O
Phenytoin	O
(Suspension)	O
300	O
mg	O
PO	O
3X/WEEK	O
(___)	O
21.	O
Phenytoin	O
(Suspension)	O
400	O
mg	O
PO	O
4X/WEEK	O
(___)	O
Discharge	O
Disposition:	O
Extended	O
Care	O
Facility:	O
___	O
Discharge	O
Diagnosis:	O
Sepsis	O
UTI	B-Urinary_tract_infection
Pneumonia	B-Lower_respiratory_tract_infection
with	O
parapneumonic	B-Lower_respiratory_tract_infection
effusion	O
Chest	O
tube	O
placement	O
Delirium	B-Delirium
Acute	O
renal	O
failure	O
Discharge	O
Condition:	O
Mental	O
Status:	O
Confused	B-Dementia
-	O
sometimes.	O
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Mobile_with_assistance
-	O
requires	O
assistance	B-Mobile_with_assistance
or	O
aid	B-Mobile_with_aid
(walker	O
or	O
cane).	O
Discharge	O
Instructions:	O
Dear	O
___	O
___	O
were	O
admitted	O
for	O
confusion	B-Delirium
and	O
altered	B-Delirium
mental	B-Delirium
status.	B-Delirium
___	O
were	O
found	O
to	O
have	O
a	O
UTI	B-Urinary_tract_infection
as	O
well	O
as	O
a	O
pneumonia.	B-Lower_respiratory_tract_infection
___	O
were	O
treated	O
with	O
antibiotics	O
however	O
___	O
developed	O
a	O
complication	O
related	O
to	O
your	O
pneumonia	B-Lower_respiratory_tract_infection
called	O
an	O
empyema	B-Lower_respiratory_tract_infection
or	O
an	O
infected	B-Lower_respiratory_tract_infection
fluid	O
collection	O
around	O
your	O
lung.	B-Lower_respiratory_tract_infection
___	O
had	O
2	O
chest	O
tubes	O
placed	O
to	O
drain	O
this	O
fluid.	O
___	O
also	O
developed	O
acute	O
renal	O
failure	O
which	O
resolved	O
with	O
IV	O
fluids.	O
Followup	O
Instructions:	O
___	O

